Bone marrow cells and rehabilitation for cerebral palsy in young children
Part of Brain & nervous system, Injuries & trauma clinical trials.
This trial tests whether transplanting cells from a child's own bone marrow, combined with rehabilitation therapy, can improve movement and function in young children with cerebral palsy caused by birth-related brain injury or bleeding. The goal is to see if this approach helps children move better and become more independent.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child is between 12 months and 6 years old
- Child has cerebral palsy (difficulty with movement and muscle control) caused by lack of oxygen or bleeding in the brain
- Child has moderate-to-severe movement limitations (GMFCS level III–V, meaning they need help with walking or cannot walk)
- Child has completed required blood work and health screening tests
- Child does not have an active infection, bleeding problems, or serious heart, liver, or kidney disease
- Child can participate in rehabilitation therapy sessions, and parents can give written permission
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether transplanting bone marrow cells can help children with spastic cerebral palsy caused by a lack of oxygen to the brain. It may improve movement and daily function.
This trial offers children with brain injuries, such as cerebral palsy or stroke, an infusion of cord blood cells that may help repair damaged brain tissue. It uses the child's own stored cord blood, a sibling's, or a matched donor's, depending on availability.
This early-phase study tests whether using a baby’s own cord blood stem cells is safe and feasible for newborns with brain injury from lack of oxygen around birth. It may help researchers find new ways to treat hypoxic-ischemic encephalopathy (brain injury due to oxygen deprivation) in addition to standard care like cooling.
This trial tests a specific type of bone marrow transplant for people with sickle cell disease (or certain other blood disorders) who have had serious complications despite standard care. It aims to see if removing the patient’s immune cells and using a matched donor’s cells can improve outcomes and reduce complications.
This study tests whether bone-marrow stem cells can improve nerve function in people with nerve damage that usually doesn’t recover with current care. It also checks whether the treatment is safe and whether people can be followed over time with repeated nerve exams.
This trial tests whether a patient's own bone marrow stem cells can help improve recovery after a moderate-to-severe ischemic stroke that happened 3 to 12 months ago.
Hear when a new Cerebral Palsy Hypoxic-Ischemic Encephalopathy Intracranial Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.